animal-vaccine-development.com
Open in
urlscan Pro
5.134.13.35
Public Scan
Submitted URL: http://animal-vaccine-development.com/
Effective URL: https://animal-vaccine-development.com/
Submission: On September 07 via api from US — Scanned from GB
Effective URL: https://animal-vaccine-development.com/
Submission: On September 07 via api from US — Scanned from GB
Form analysis
1 forms found in the DOMGET https://animal-vaccine-development.com/
<form role="search" method="get" id="searchform" class="searchform" action="https://animal-vaccine-development.com/">
<div>
<label class="screen-reader-text" for="s"> Search</label>
<input type="text" value="" name="s" id="s" placeholder="">
<input type="submit" id="searchsubmit" value="Search">
</div>
</form>
Text Content
Skip to content JUNE 26-28, 2019 BOSTON, MA Menu * Home * About * About Event * Who Attends * Venue & Accommodation * About Microbiome Movement * Media Hub * What’s On? * Full Event Guide * Speakers * Pre-Conference Workshops * Conference Day 1 * Conference Day 2 * Partner * Why Partner? * Partnership Prospectus * 2019 Partners * FAQs * Take Part * Register * Pricing * Contact Us * Home * About * About Event * Who Attends * Venue & Accommodation * About Microbiome Movement * Media Hub * What’s On? * Full Event Guide * Speakers * Pre-Conference Workshops * Conference Day 1 * Conference Day 2 * Partner * Why Partner? * Partnership Prospectus * 2019 Partners * FAQs * Take Part * Register * Pricing * Contact Us RETURNING FOR 4TH YEAR JUNE 26-28, 2019 BOSTON, MA 2023 EVENT GUIDE SECURE YOUR PLACE PARTNER Welcome to the 8th Oncolytic Virotherapy Summit: Engineering Oncolytic Viruses Towards Revolutionary Anti-Cancer Immunotherapies Recent years have seen highly promising and rapid advances in the pre-clinical development and clinical evolution of oncolytic virotherapies. They are increasingly being recognised as a therapy with huge potential to change the landscape for cancer immunotherapy. In the past 3 months alone, we have witnessed 20 new drugs entering into pre-clinical and clinical phases, and exciting FDA Fast Track Designation for Candel Therapeutics OV candidate - this community continues to maximize the impact of these hopeful therapies. EXPERT SPEAKER FACULTY INCLUDES: Unite with 100+ OV trailblazers across sessions spanning Early Discovery, Translation, Clinical Development, Chemistry, Manufacturing & Controls (CMC) and Regulations to overcome the industry's largest and critical bottlenecks. Meet your community to hear how they address the major challenges facing the industry: Investigate the Manufacturing Challenges & Approaches to Produce a Successful Oncolytic Virus to Ensure its Quality, Traceability, & Reliability Understand the raw materials and supply chain management of your oncolytic virus and, explore the importance of stability of your viral vectors with insights from VYRIAD & Circio Bio Optimize the Immunogenicity of Your Oncolytic Virus Candidate: Maximizing Effectiveness & Minimizing Side Effects in Cancer Treatment Discuss the current immunogenicity studies to support FIM studies and assess the safety and efficacy of your oncolytic virus with insights from Boehringer Ingelheim & Omios Biologics Review How to Bridge the Gap Between Pharma, Biotech & Investors to Facilitate the Growth & Development of This Field Address the importance of collaboration and investment in advancing pharma and biotech innovations, and discuss the strategies for mitigating risks and maximizing returns on investment with insights from Candel Therapeutics & Valo Therapeutics Discover the Potential of Using Combination Therapy for Improved Therapeutic Outcomes Investigate the innovative combinations of oncolytic viruses with other therapeutic modalities as well as review the current pre-clinical and clinical studies demonstrating anti-tumor efficacy with insights from Replimune & Oncolys Explore the Latest Clinical Data & How to Design Better Clinical Trials to Develop More Effective Oncolytic Virus's Discussing the most up to date clinical data on advancements in oncolytic viruses and what are the possible breakthroughs and innovations we may see in the next year with insights from Lokon Pharma & Calidi Therapeutics PAST ATTENDEES INCLUDE: 2023 EVENT GUIDE BACK TO TOP OUR CONTACT DETAILS T: (+1) 617 455 4188 E: info@hansonwade.com VENUE DETAILS Revere Hotel Boston Common 200 Stuart St Boston MA 02116 USA ABOUT US Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. LOCATION SEARCH Search ORGANISED BY TERMS & CONDITIONS © Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216. Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.